Jack A. Khattar - President, CEO, Director at Supernus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO, Director
Stock Symbol
SUPN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jack A. Khattar since 9/18/2023

Holdings reported by Jack A. Khattar for Supernus Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.02M $35.7M $34.90 Sep 3, 2024 By the KBT Trust
Common Stock 926K $32.3M $34.90 Sep 3, 2024 Direct
Performance Share Unit 0 $0 $34.90 Sep 3, 2024 Direct Common Stock
Employee Stock Option (Right to Buy) 322K Feb 22, 2024 Direct Common Stock

Transactions reported by Jack A. Khattar for Supernus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.